Ming-Liang He

InstitutionCity University of Hong Kong
AddressHong Kong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 2 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 114 publications over 21 distinct years, with a maximum of 13 publications in 2009
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wan Q, Song D, Li H, He ML. Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development. Signal Transduct Target Ther. 2020 07 13; 5(1):125. PMID: 32661235.
      Citations: 17     Translation:HumansCellsPHPublic Health
    2. Chan W, He B, Wang X, He ML. Pandemic COVID-19: Current status and challenges of antiviral therapies. Genes Dis. 2020 Dec; 7(4):502-519. PMID: 32837984.
      Citations: 2     
    3. Xie Q, Cao Y, Su J, Wu J, Wu X, Wan C, He M, Ke C, Zhang B, Zhao W. Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms. Arch Virol. 2017 08; 162(8):2445-2449. PMID: 28421366.
      Citations: 9     Fields:    Translation:HumansCells
    4. Yang N, Tanner JA, Zheng BJ, Watt RM, He ML, Lu LY, Jiang JQ, Shum KT, Lin YP, Wong KL, Lin MC, Kung HF, Sun H, Huang JD. Bismuth complexes inhibit the SARS coronavirus. Angew Chem Int Ed Engl. 2007; 46(34):6464-8. PMID: 17645269.
      Citations: 27     Fields:    Translation:HumansCells
    5. He ML, Zheng BJ, Chen Y, Wong KL, Huang JD, Lin MC, Peng Y, Yuen KY, Sung JJ, Kung HF. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. FEBS Lett. 2006 May 01; 580(10):2414-20. PMID: 16638566.
      Citations: 19     Fields:    Translation:AnimalsCells
    6. Tanner JA, Zheng BJ, Zhou J, Watt RM, Jiang JQ, Wong KL, Lin YP, Lu LY, He ML, Kung HF, Kesel AJ, Huang JD. The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. Chem Biol. 2005 Mar; 12(3):303-11. PMID: 15797214.
      Citations: 68     Fields:    Translation:AnimalsCells
    7. Bernini A, Spiga O, Ciutti A, Chiellini S, Bracci L, Yan X, Zheng B, Huang J, He ML, Song HD, Hao P, Zhao G, Niccolai N. Prediction of quaternary assembly of SARS coronavirus peplomer. Biochem Biophys Res Commun. 2004 Dec 24; 325(4):1210-4. PMID: 15555555.
      Citations: 11     Fields:    Translation:Cells
    8. Zheng B, He ML, Wong KL, Lum CT, Poon LL, Peng Y, Guan Y, Lin MC, Kung HF. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J Interferon Cytokine Res. 2004 Jul; 24(7):388-90. PMID: 15296649.
      Citations: 40     Fields:    Translation:HumansCells
    9. Zheng BJ, Guan Y, Tang Q, Du C, Xie FY, He ML, Chan KW, Wong KL, Lader E, Woodle MC, Lu PY, Li B, Zhong N. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. Antivir Ther. 2004 Jun; 9(3):365-74. PMID: 15259899.
      Citations: 37     Fields:    Translation:AnimalsCells
    10. He ML, Zheng B, Peng Y, Peiris JS, Poon LL, Yuen KY, Lin MC, Kung HF, Guan Y. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA. 2003 Nov 26; 290(20):2665-6. PMID: 14645307.
      Citations: 40     Fields:    Translation:HumansAnimalsCells